Transcriptional Profiling of Peripheral Blood in Pancreatic Adenocarcinoma Patients Identifies Diagnostic Biomarkers

Octavio Caba,Jose Prados,Raúl Ortiz,Cristina Jimenez-Luna,Consolación Melguizo,Pablo Álvarez,J.R. Delgado,Antonio Irigoyen,Ignacio Rojas,Javier Pérez-Florido,Carolina Torres,Sonia Perales,A. Linares,Antonia Aránega

Transcriptional Profiling of Peripheral Blood in Pancreatic Adenocarcinoma Patients Identifies Diagnostic Biomarkers

2014

Octavio Caba
Jose Prados
Raúl Ortiz
Cristina Jimenez-Luna
Consolación Melguizo
Pablo Álvarez
J.R. Delgado
Antonio Irigoyen
Ignacio Rojas
Javier Pérez-Florido
Carolina Torres
Sonia Perales
A. Linares
Antonia Aránega

Background Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy associated with poor survival rates. Fast detection of PDAC appears to be the most relevant strategy to improve the long-term survival of patients.

Keywords:

Diabetes mellitus
Gene expression profiling
CDNA Microarrays
Medicine
Peripheral
Biomarker (medicine)
Adenocarcinoma
Malignancy
Internal medicine
Oncology
Microarray
Gene prediction
Hepatology
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations